BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3576612)

  • 21. Cisplatin pharmacokinetics and its nephrotoxicity in diabetic rabbits.
    Najjar TA; Saad SY
    Chemotherapy; 2001; 47(2):128-35. PubMed ID: 11173815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ameliorative effects of ceftriaxone and vitamin E against cisplatin-induced nephrotoxicity.
    Abdel-Daim MM; Aleya L; El-Bialy BE; Abushouk AI; Alkahtani S; Alarifi S; Alkahtane AA; AlBasher G; Ali D; Almeer RS; Al-Sultan NK; Alghamdi J; Alahmari A; Bungau SG
    Environ Sci Pollut Res Int; 2019 May; 26(15):15248-15254. PubMed ID: 30929167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine.
    Saad SY; Najjar TA; Daba MH; Al-Rikabi AC
    Chemotherapy; 2002; 48(6):309-15. PubMed ID: 12673106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on protective effect of selenium on the nephrotoxicity of cis-diamminedichloroplatinum (CDDP) in mice].
    Araya Y
    Hokkaido Igaku Zasshi; 1990 May; 65(3):245-53. PubMed ID: 2165995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic protective effect of
    Abdel-Wahab WM; Moussa FI; Saad NA
    Drug Des Devel Ther; 2017; 11():901-908. PubMed ID: 28356716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of L-histidinol on cisplatin nephrotoxicity in the rat.
    Badary OA; Nagi MN; Al-Sawaf HA; Al-Harbi M; Al-Bekairi AM
    Nephron; 1997; 77(4):435-9. PubMed ID: 9434066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments.
    Yajima Y; Kawaguchi M; Yoshikawa M; Okubo M; Tsukagoshi E; Sato K; Katakura A
    J Pharmacol Sci; 2017 Jun; 134(2):108-115. PubMed ID: 28648300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection effects of Taurine supplementation against cisplatin-induced nephrotoxicity in rats.
    Saad SY; Al-Rikabi AC
    Chemotherapy; 2002 Mar; 48(1):42-8. PubMed ID: 11901256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity in rats: importance of area under the concentration-time curve (AUC) as the major toxicodynamic determinant in vivo.
    Nagai N; Ogata H
    Cancer Chemother Pharmacol; 1997; 40(1):11-8. PubMed ID: 9137523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway.
    Elsayed AM; Abdelghany TM; Akool el-S; Abdel-Aziz AA; Abdel-Bakky MS
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Mar; 389(3):327-37. PubMed ID: 26659823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid peroxides and antioxidant enzymes in cisplatin-induced chronic nephrotoxicity in rats.
    González R; Romay C; Borrego A; Hernández F; Merino N; Zamora Z; Rojas E
    Mediators Inflamm; 2005 Aug; 2005(3):139-43. PubMed ID: 16106099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-activating factor antagonist, BN-52021 protects against cis-diamminedichloroplatinum nephrotoxicity in the rat.
    Pirotzky E; Guilmard C; Sidoti C; Ivanow F; Principe P; Braquet P
    Ren Fail; 1990; 12(3):171-6. PubMed ID: 2287769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of dosing time and schedule on cisplatin-induced nephrotoxicity in rats.
    Kobayashi M; To H; Yuzawa M; Hakamata Y; Higuchi S; Tokue A; Fujimura A; Kobayashi E
    J Pharm Pharmacol; 2000 Oct; 52(10):1233-7. PubMed ID: 11092567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the renin-angiotensin system in cisplatin nephrotoxicity.
    Deegan PM; Nolan C; Ryan MP; Basinger MA; Jones MM; Hande KR
    Ren Fail; 1995 Nov; 17(6):665-74. PubMed ID: 8771239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of nephrotoxicity in the rat during repeated cis-platinum treatments.
    Jones MM; Basinger MA
    J Appl Toxicol; 1989 Aug; 9(4):229-33. PubMed ID: 2778256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tiopronin protects against the nephrotoxicity of cisplatin in the rat.
    Zhang JG; Viale M; Esposito M; Lindup WE
    Hum Exp Toxicol; 1999 Dec; 18(12):713-7. PubMed ID: 10627657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic effect of methylprednisolone against cisplatin-induced nephrotoxicity in rats.
    Koikawa Y; Uozumi J; Ueda T; Yasumasu T; Kumazawa J
    Toxicol Lett; 1993 Mar; 66(3):281-5. PubMed ID: 8475508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of mycophenolate mofetil on cisplatin-induced renal dysfunction in rats.
    Saad SY; Arafah MM; Najjar TA
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):455-60. PubMed ID: 16855841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors for Cisplatin-Induced Nephrotoxicity: A Multicenter Retrospective Study.
    Miyoshi T; Uoi M; Omura F; Tsumagari K; Maesaki S; Yokota C
    Oncology; 2021; 99(2):105-113. PubMed ID: 32966986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of oral administration of Arabic gum on cisplatin-induced nephrotoxicity in rats.
    Al-Majed AA; Abd-Allah AR; Al-Rikabi AC; Al-Shabanah OA; Mostafa AM
    J Biochem Mol Toxicol; 2003; 17(3):146-53. PubMed ID: 12815610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.